FABP4 and breast cancer: Breast cancer patients display higher blood concentration of FABP4, implying elevated levels of circulating FABP4 as a specific promoter of the obesity-associated breast cancer (Guaita-Esteruelas et al., 2017a; Zeng et al., 2020).